Cotavance™ Paclitaxel-Coated Balloon Versus Uncoated Balloon Angioplasty for Treatment of In-stent Restenosis in SFA and Popliteal Arteries

NCT01594684 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 112

Last updated 2012-06-19

No results posted yet for this study

Summary

In stent restenosis in peripheral artery disease (superficial and popliteal artery) either treated with uncoated or paclitaxel coated balloons.

Conditions

  • Catherization

Interventions

DEVICE

balloon angiolplasty - drug coated balloon (Cotavance, Medrad Inc.)

balloon inflation

DEVICE

drug coated balloon inflation (Cotavance, Medrad Inc.)

Balloon inflation

DEVICE

uncoated balloon (e.g. Admiral, Medtronic)

balloon inflation

DEVICE

balloon inflation, drug coated balloon (Cotavance, Medrad Inc.)

ballon inflation

Sponsors & Collaborators

  • Zeller

    collaborator UNKNOWN
  • Duda

    collaborator UNKNOWN
  • Albrecht

    collaborator UNKNOWN
  • Reimer

    collaborator UNKNOWN
  • Brechtel

    collaborator UNKNOWN
  • Diehm

    collaborator UNKNOWN
  • Strausinsky

    collaborator UNKNOWN
  • Jahnke

    collaborator UNKNOWN
  • Huppert

    collaborator UNKNOWN
  • Amendt

    collaborator UNKNOWN
  • Prof. Dr. med. Gunnar Tepe

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2014-01-31
Completion
2016-06-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01594684 on ClinicalTrials.gov